Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18087/cardio.2020.6.n1180 http://scihub22266oqcxt.onion/10.18087/cardio.2020.6.n1180 32720611!ä!32720611 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Kardiologiia 2020 ; 60 (6): 1180 Nephropedia Template TP {{tp|p=32720611|t=2020. Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19 The Agreed Experts Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association |pdf=|usr=}}{{32720611}} gab.com Text Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19 The Agreed Experts Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association JO: Kardiologiia http://www.kidney.de/pget.php?&tw=1&pmid=32720611 #FOAvip This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed. Twit Text FOAVip Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19 The Agreed Experts Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association ????Kardiologiia http://www.kidney.de/pget.php?&tw=1&pmid=32720611 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32720611 #FOAvip English Wikipedia <ref>{{Cite pmid|32720611}}</ref> Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19 The Agreed Experts Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association #MMPMID32720611 Shlyakhto YV; Arutyunov GP; Belenkov YN; Tarlovskaya EI; Konradi AO; Panchenko EP; Yavelov IS; Tereshchenko SN; Ardashev AV; Arutyunov AG; Grigorieva NY; Dzhunusbekova GA; Drapkina OM; Koziolova NA; Komarov AL; Kropacheva ES; Malchikova SV; Mitkovskaya NP; Orlova YA; Petrova MM; Rebrov AP; Sisakian H; Skibitsky VV; Sugraliyev AB; Fomin IV; Chesnikova AI; Shaposhnik II; Zhelyakov EG; Kanorskii SG; Kolotsey LV; Snezhitskiy VA Kardiologiia 2020[May]; 60 (6): 1180 PMID32720611show ga This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed. |*Anticoagulants/therapeutic use[MESH] |*Cardiology[MESH] |*Coronavirus Infections/drug therapy/epidemiology[MESH] |*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/drug therapy/epidemiology[MESH] |Anti-Arrhythmia Agents/therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Humans[MESH] |Russia[MESH] |SARS-CoV-2[MESH] Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Dru(epmc).pdf DeepDyve Pubget Overpricing